Lipocine Inc (LPCN)
4.68
-0.02
(-0.43%)
USD |
NASDAQ |
May 03, 16:00
4.60
-0.08
(-1.71%)
After-Hours: 20:00
Lipocine 1 Year Total Returns (Daily): 10.12% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 10.12% |
| May 02, 2024 | 4.49% |
| May 01, 2024 | 2.46% |
| April 30, 2024 | 4.52% |
| April 29, 2024 | 7.01% |
| April 26, 2024 | 4.49% |
| April 25, 2024 | -6.35% |
| April 24, 2024 | -9.97% |
| April 23, 2024 | -3.96% |
| April 22, 2024 | 1.44% |
| April 19, 2024 | 1.64% |
| April 18, 2024 | 5.23% |
| April 17, 2024 | 9.69% |
| April 16, 2024 | -1.86% |
| April 15, 2024 | 10.41% |
| April 12, 2024 | 11.80% |
| April 11, 2024 | 20.47% |
| April 10, 2024 | 24.33% |
| April 09, 2024 | 6.07% |
| April 08, 2024 | -3.31% |
| April 05, 2024 | -11.74% |
| April 04, 2024 | -14.05% |
| April 03, 2024 | -8.49% |
| April 02, 2024 | -8.09% |
| April 01, 2024 | -1.99% |
| Date | Value |
|---|---|
| March 28, 2024 | -6.74% |
| March 27, 2024 | -4.68% |
| March 26, 2024 | -0.91% |
| March 25, 2024 | -12.97% |
| March 22, 2024 | -27.50% |
| March 21, 2024 | -26.96% |
| March 20, 2024 | -23.51% |
| March 19, 2024 | -27.91% |
| March 18, 2024 | -24.02% |
| March 15, 2024 | -12.40% |
| March 14, 2024 | -19.00% |
| March 13, 2024 | -26.07% |
| March 12, 2024 | -24.25% |
| March 11, 2024 | -30.94% |
| March 08, 2024 | -51.75% |
| March 07, 2024 | -50.62% |
| March 06, 2024 | -53.20% |
| March 05, 2024 | -51.27% |
| March 04, 2024 | -51.14% |
| March 01, 2024 | -48.80% |
| February 29, 2024 | -50.34% |
| February 28, 2024 | -49.43% |
| February 27, 2024 | -49.54% |
| February 26, 2024 | -47.24% |
| February 23, 2024 | -50.30% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-85.71%
Minimum
Mar 17 2020
496.7%
Maximum
Mar 17 2021
-3.81%
Average
-41.80%
Median
Jun 16 2020
1 Year Total Returns (Daily) Benchmarks
| Alpine Immune Sciences Inc | 824.2% |
| Eliem Therapeutics Inc | 196.9% |
| NovaBay Pharmaceuticals Inc | -90.79% |
| Palatin Technologies Inc | -3.65% |
| iBio Inc | -90.87% |